Steven Gillis

Insider Reports History

Location
Chicago, IL
Signature
/s/ Max Heuer, by power of attorney, for Steven Gillis
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Gillis:

Company Role Class Num Shares Value Price $ Report Date Ownership
VBI Vaccines Inc/BC Director Common Shares, no par value per share 1,043,292 $1,721,432 $1.65 10 Jul 2023 Indirect
Homology Medicines, Inc. Director Option (Right to Buy) 23,000 $308,660 $13.42 14 Jun 2023 Direct
VBI Vaccines Inc/BC Director Common Shares, no par value per share 2,814 $4,643 $1.65 10 Jul 2023 Direct
VBI Vaccines Inc/BC Director Warrant (right to buy) 609,090 10 Jul 2023 Indirect
VBI Vaccines Inc/BC Director Option (Right to Buy Common Shares) 52,500 27 Jul 2023 Direct
TAKEDA PHARMACEUTICAL CO LTD Director American Depositary Shares 15,857 18 Mar 2026 Direct
TAKEDA PHARMACEUTICAL CO LTD Director Ordinary Shares 9,700 18 Mar 2026 Direct
Codiak BioSciences, Inc. Director Common Stock 8,750 16 Feb 2023 Direct
Codiak BioSciences, Inc. Director Restricted Stock Units 0 16 Feb 2023 Direct

Insider Reports Filed by Steven Gillis